TAK icon

Takeda Pharmaceutical

309 hedge funds and large institutions have $1.2B invested in Takeda Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 134 increasing their positions, 65 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
309
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26.6M
Puts
$216K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AAS
276
Ameritas Advisory Services
Nebraska
$1.7K
PWA
277
Physician Wealth Advisors
Utah
$1.67K
WTC
278
WhitTier Trust Company
Nevada
$1.62K
HPC
279
HM Payson & Co
Maine
$1.55K
EPIMS
280
Evelyn Partners Investment Management Services
$1.52K
AT
281
Arlington Trust
Alabama
$1.39K
FRA
282
Front Row Advisors
California
$1.33K
RI
283
Ridgewood Investments
New Jersey
$1.11K
GC
284
Gould Capital
Washington
$1.08K
CI
285
CX Institutional
Indiana
$1K
WA
286
WPG Advisers
Maryland
$974
BLC
287
Brown, Lisle/Cummings
Rhode Island
$897
PWAM
288
Private Wealth Asset Management
Iowa
$819
SIS
289
Sound Income Strategies
Florida
$740
FG
290
Fairman Group
Pennsylvania
$711
SL
291
Salomon & Ludwin
Virginia
$632
BA
292
Bellwether Advisors
Nebraska
$557
CA
293
Clearstead Advisors
Ohio
$387
AAG
294
Armstrong Advisory Group
Massachusetts
$387
ICM
295
Islay Capital Management
Texas
$387
AP
296
Atwood & Palmer
Missouri
$387
Kayne Anderson Rudnick Investment Management
297
Kayne Anderson Rudnick Investment Management
California
$325
AWM
298
Abound Wealth Management
Tennessee
$310
CWP
299
Concord Wealth Partners
Virginia
$309
AF
300
Advisornet Financial
Minnesota
$309